Detalhe da pesquisa
1.
Chimeric Antigen Receptors Targeting Human Cytomegalovirus.
J Infect Dis
; 222(5): 853-862, 2020 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285133
2.
Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types.
J Virol
; 93(16)2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31142670
3.
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
J Virol
; 92(19)2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045984
4.
MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.
Blood
; 129(1): 114-125, 2017 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760761
5.
Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.
J Virol
; 91(6)2017 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077639
6.
Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.
Proc Natl Acad Sci U S A
; 112(44): 13645-50, 2015 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26483473
7.
Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.
J Virol
; 89(23): 11884-98, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26378171
8.
Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.
PLoS Pathog
; 10(11): e1004524, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25412505
9.
Correction for Chiuppesi et al., "Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice".
J Virol
; 93(23)2019 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31723009
10.
A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.
J Virol
; 87(3): 1322-32, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23152525
11.
Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform.
NPJ Vaccines
; 9(1): 68, 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555379
12.
Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.
Commun Med (Lond)
; 4(1): 19, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366141
13.
Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants.
NPJ Vaccines
; 8(1): 41, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928589
14.
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy.
Vaccines (Basel)
; 11(9)2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766168
15.
COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants.
iScience
; 25(6): 104457, 2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634578
16.
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates.
NPJ Vaccines
; 7(1): 7, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064109
17.
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants.
iScience
; 25(8): 104745, 2022 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846380
18.
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial.
Lancet Microbe
; 3(4): e252-e264, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35287430
19.
Protection against Congenital CMV Infection Conferred by MVA-Vectored Subunit Vaccines Extends to a Second Pregnancy after Maternal Challenge with a Heterologous, Novel Strain Variant.
Viruses
; 13(12)2021 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34960820
20.
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates.
bioRxiv
; 2021 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34545366